In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

The Medtronic Symplicty Spyral renal denervation ... The approvals reflect CMS’s recognition of these devices as breakthrough technologies representing significant clinical advances in managing ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. The Total REALITY study retrospectively compared ...

Medtronic acquired the Sphere-9 catheter for pulsed field ablation (PFA), radiofrequency (RF) ablation and cardiac mapping in its 2022 purchase of device developer Affera for up to $1 billion. In 2023 ...

While companies haven’t disclosed the exact terms of the settlements, Medtronic has begun educating physicians about the shortcomings of its devices and providing QR codes on its devices that ...

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

Finally, Medtronic will cap off the earnings season on Nov. 19. Company leaders will likely field questions about the recent FDA approval of a new pulsed field ablation device, which could give ...